Cochlear share price clings to 52-week low after broker warning on Nexa rollout — what investors watch next

Cochlear Ltd finished Tuesday at A$199.81, slipping 0.34%. Shares are still hovering just above the 52-week low, sitting roughly 37% under this year’s high. Investors remain uneasy about ongoing issues tied to the company’s launch of the Nucleus Nexa implant system.